| Name | BRD0539 |
|---|
| Description | BRD0539 is a cell-permeable and non-toxic inhibitor of CRISPR-Cas9. BRD0539 inhibits Streptococcus pyogenes Cas9 (SpCas9) (apparent IC50=22 μM) in an in vitro DNA cleavage assay[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 22 μM (SpCas9)[1] |
| In Vitro | BRD0539 dose-dependently blocks the formation of the DNA-bound state in a dose-dependent fashion. BRD0539 impairs the perturbation induced by the 4PAM DNA[1]. BRD0539 does not interfere with the SpCas9:gRNA interaction[1]. BRD0539 is able to inhibit SpCas9 in the eGFP-disruption assay, BRD0539 is unable to inhibit FnCpf1, a structurally different CRISPR-associated nuclease, in the same assay, further highlighting the specificity of BRD0539[1]. |
| References |
| Molecular Formula | C25H25FN2O3S |
|---|---|
| Molecular Weight | 452.54 |